You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine
|
---|---|
Published in |
Frontiers in Pharmacology, November 2023
|
DOI | 10.3389/fphar.2023.1246892 |
Pubmed ID | |
Authors |
Dario A. Dornbierer, Laurenz Marten, Jovin Mueller, Helena D. Aicher, Michael J. Mueller, Martina Boxler, Michael Kometer, Davor Kosanic, Robin von Rotz, Maxim Puchkov, Thomas Kraemer, Hans-Peter Landolt, Erich Seifritz, Milan Scheidegger |
X Demographics
The data shown below were collected from the profiles of 49 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 10 | 20% |
United Kingdom | 6 | 12% |
Brazil | 2 | 4% |
Canada | 2 | 4% |
Japan | 1 | 2% |
Germany | 1 | 2% |
Peru | 1 | 2% |
Ireland | 1 | 2% |
Colombia | 1 | 2% |
Other | 3 | 6% |
Unknown | 21 | 43% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 37 | 76% |
Scientists | 10 | 20% |
Practitioners (doctors, other healthcare professionals) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 13 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 3 | 23% |
Student > Ph. D. Student | 2 | 15% |
Other | 2 | 15% |
Student > Postgraduate | 2 | 15% |
Unknown | 4 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 3 | 23% |
Neuroscience | 2 | 15% |
Medicine and Dentistry | 1 | 8% |
Unknown | 7 | 54% |
Attention Score in Context
This research output has an Altmetric Attention Score of 36. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 December 2023.
All research outputs
#1,127,755
of 25,563,770 outputs
Outputs from Frontiers in Pharmacology
#425
of 19,933 outputs
Outputs of similar age
#17,788
of 358,941 outputs
Outputs of similar age from Frontiers in Pharmacology
#5
of 660 outputs
Altmetric has tracked 25,563,770 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,933 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 358,941 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 660 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.